NYTNYT·3hPolitics
score-0.40
Health Officials Allow Some Levels of Opioid in Products After Kratom Industry Lobbying
Original
Trump Administration Backs Down on an Opioid Ban After Kratom Industry Lobbying
“Framing emphasizes regulatory retreat driven by corporate lobbying and specific donor interests, highlighting systemic bias over public health.”